
Company Info
Year Established2017
Contacts
Stefan Scherer, MD, PhDPresident & CEO
Christopher J DeRespino
CBO
Sean Harper, MD
Chair
Bryan A. Irving Ph.D.
CSO
Estelle Marrer-Berger, Ph.D.
CDO
Company Description
3T is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient populations.